A federal judge denied Teva's bid to delay the first Paragard bellwether trial, keeping a January start date for claims tied ...

Please provide your email address to receive an email when new articles are posted on . Ovaprene, a monthly hormone-free contraceptive, blocked motile sperm in an early-phase study. There were no ...

Please provide your email address to receive an email when new articles are posted on . Levonorgestrel-releasing intrauterine system users vs. nonusers had an increased risk for breast cancer. Breast ...

According to a French study, women using the Jaydess intrauterine device (IUD) faced a two to four times higher risk of ...

Newly issued patent covers a new medical device and method to deliver and remove hydrogel within the body, including Plan A™’s sperm occlusion system. We have been thoughtfully innovating for several ...

(Reuters) - The U.S. Food and Drug Administration approved a hormonal contraceptive device on Friday that gives American women another reversible contraceptive choice as effective as sterilization.

Teva Pharmaceuticals can’t delay the first trial in thousands of lawsuits over claims its Paragard intrauterine contraceptive ...

Social media users advising women to get IUDs before Trump takes office. — -- Online searches for long-acting birth control devices spiked significantly in the hours after the presidential ...